|
Volumn 6, Issue 2, 2002, Pages 88-93
|
Osteoporosis in men treated with androgen suppression therapy for prostate cancer.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
GONADORELIN;
BONE DENSITY;
BONE REMODELING;
DRUG EFFECT;
DRUG POTENTIATION;
HUMAN;
MALE;
NURSE ATTITUDE;
OSTEOPOROSIS;
PATHOPHYSIOLOGY;
PATIENT EDUCATION;
PROSTATE TUMOR;
REVIEW;
RISK FACTOR;
ANTINEOPLASTIC AGENTS, HORMONAL;
BONE DENSITY;
BONE REMODELING;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
MALE;
NURSE'S ROLE;
OSTEOPOROSIS;
PATIENT EDUCATION;
PROSTATIC NEOPLASMS;
RISK FACTORS;
|
EID: 0036512793
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/02.CJON.88-93 Document Type: Review |
Times cited : (13)
|
References (51)
|